Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Marvel Biosciences Corp (MRVL.VN)
Marvel Biosciences Corp (MRVL.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 5,172
  • Shares Outstanding, K 39,786
  • Annual Sales, $ 0 K
  • Annual Income, $ -2,291 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MRVL.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.06
  • Most Recent Earnings $-0.01 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.095 +36.84%
on 01/26/24
0.190 -31.58%
on 02/07/24
+0.035 (+36.84%)
since 01/23/24
3-Month
0.075 +73.33%
on 12/19/23
0.190 -31.58%
on 02/07/24
+0.055 (+73.33%)
since 11/23/23
52-Week
0.010 +1,200.00%
on 10/02/23
0.190 -31.58%
on 02/07/24
+0.025 (+23.81%)
since 02/23/23

Most Recent Stories

More News
Marvel Biosciences Announces Testing MB-204 on Autism by French University

Calgary, Alberta--(Newsfile Corp. - February 20, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"),...

MBCOF : 0.1032 (-17.44%)
MRVL.VN : 0.130 (-7.14%)
Marvel Biosciences Announces Closing of Non-Brokered Private Placement

Calgary, Alberta--(Newsfile Corp. - January 19, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased...

MBCOF : 0.1032 (-17.44%)
MRVL.VN : 0.130 (-7.14%)
Marvel Biosciences to Collaborate with Tau Expert Dr. Emmanuel Planel

Calgary, Alberta--(Newsfile Corp. - January 8, 2024) -  Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or...

MBCOF : 0.1032 (-17.44%)
MRVL.VN : 0.130 (-7.14%)
Marvel Biosciences Invited to Test MB-204 on Autism by French University

Calgary, Alberta--(Newsfile Corp. - November 16, 2023) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"),...

MBCOF : 0.1032 (-17.44%)
MRVL.VN : 0.130 (-7.14%)
Stocks in play: Marvel Biosciences Corp

Announces that it has successfully completed its 4-week good laboratory practice, FDA investigational ...

MRVL.VN : 0.130 (-7.14%)
Marvel Announces Successful Completion of Toxicology Study in Preparation for Phase 1 Human Trials

Calgary, Alberta--(Newsfile Corp. - August 22, 2023) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"),...

MBCOF : 0.1032 (-17.44%)
MRVL.VN : 0.130 (-7.14%)
Stocks in play: Marvel Biosciences Corp

Announces it has been selected to present the Company's scientific advancement of its key asset MB-204 ...

MRVL.VN : 0.130 (-7.14%)
Marvel Highlights Key Asset at the 2023 Alzheimer's Association International Conference

Calgary, Alberta--(Newsfile Corp. - July 10, 2023) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased...

MRVL.VN : 0.130 (-7.14%)
Marvel Successfully Completes the Dog and Rat GLP Toxicology Studies Required to Enter Human Trials

Calgary, Alberta--(Newsfile Corp. - April 20, 2023) -  Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased...

MRVL.VN : 0.130 (-7.14%)
Stocks in play: Marvel Biosciences Corp

Announces that along with its wholly owned subsidiary, Marvel Biotechnology Inc., it has completed the ...

MRVL.VN : 0.130 (-7.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.147
2nd Resistance Point 0.143
1st Resistance Point 0.137
Last Price 0.130
1st Support Level 0.127
2nd Support Level 0.123
3rd Support Level 0.117

See More

52-Week High 0.190
Last Price 0.130
Fibonacci 61.8% 0.121
Fibonacci 50% 0.100
Fibonacci 38.2% 0.079
52-Week Low 0.010

See More

Business Summary

Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar